Sifted’s in-depth report on the European psychedelic landscape featuring PAREA

“Despite numerous hurdles, it seems only a matter of time before psychedelics receive (some form of) regulatory green light in Europe.” This is how Sifted.eu - a Financial Times-backed media company covering startups and innovation in Europe – starts its in-dept report “Psychedelics for mental health. Ready for the renaissance”

This Europe-focused report assesses which psychedelic compounds are advancing through the clinical trial process. Analysing which might be best suited to a modern medical model, and considering the various risks of implementation.

This report also studies the regulatory landscape in Europe and asks which markets might open up to psychedelic healthcare soonest. Finally, it looks at the commercial models for psychedelic healthcare companies already functioning in Europe, as well as the emerging digital technologies to try and scale these treatments faster.

PAREA’s Executive Director Tadeusz Hawrot is one of the report’s contributors in Chapter two on European access.